Baker Avenue Asset Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-180
Closed -$466 509
2023
Q3
$466 Hold
180
﹤0.01% 1478
2023
Q2
$709 Hold
180
﹤0.01% 1290
2023
Q1
$608 Buy
+180
New +$734 ﹤0.01% 1351

Other funds holding SRTA

Baker Avenue Asset Management's SRTA Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of Strata Critical Medical Inc (SRTA) in Q4 2023, closing a stake of 180 shares — an estimated $466 sold.

Baker Avenue Asset Management first reported a position in SRTA in Q1 2023 and held it in 3 quarters. The position peaked at $709 in Q2 2023. 102 funds tracked by Wall St. Rank hold SRTA as of Q4 2023.

  • Baker Avenue Asset Management reported no remaining Strata Critical Medical Inc position as of Q4 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 180 Strata Critical Medical Inc shares in Q4 2023, an estimated $466.
  • Baker Avenue Asset Management first reported a position in Strata Critical Medical Inc in Q1 2023 and held it in 3 quarters.
  • Baker Avenue Asset Management's Strata Critical Medical Inc position peaked at $709 in Q2 2023.
  • 102 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.